Skip to content
Aminoscope
← The desk
Peptides & longevity

Theo Lindqvist

The peptide and healthspan frontier, sorted by what actually has human data.

ORCID iD: 0009-0009-2553-5574

Theo Lindqvist is a pen name used by a writer at Aminoscope, published by MEAS Partners, LLC. Theo covers the peptide and longevity landscape — BPC-157, NAD+ precursors, senolytics, mitochondrial interventions — always grading findings by their evidence tier: human trials, animal models, or in-vitro only.

What they cover

  • Therapeutic peptides and research peptides
  • NAD+ precursors and mitochondrial health
  • Senolytics and cellular senescence
  • Healthspan and longevity interventions
  • Evidence grading for preclinical vs. clinical data
  • BPC-157, TB-500, and growth hormone secretagogues
Browse all researchAbout Aminoscope